VEGFA and neoplasm: Therefore, regardless of the different tumor models and independent of the length of anti-VEGF treatment, the VDGs consistently reflected the anti-vascular consequences of VEGF signaling inhibition and likely correlated with the VEGF pathway bioactivity in tumor samples.